Copyright
©2010 Baishideng Publishing Group Co.
World J Hepatol. Dec 27, 2010; 2(12): 442-446
Published online Dec 27, 2010. doi: 10.4254/wjh.v2.i12.442
Published online Dec 27, 2010. doi: 10.4254/wjh.v2.i12.442
Figure 2 Clinical course of the present case.
After switching from ADV plus LAM to ETV, serum levels of P and ALP improved, and the patient’s bone pain also decreased dramatically. ADV: adefovir dipivoxil; LAM: lamivudine; ETV: entecavir hydrate; PSL: prednisolone; P: phosphate; APL: alkaline phosphatase; γ-GTP: γ-glutamyl transferase; LDLT: living donor-related liver transplantation.
- Citation: Minemura M, Tokimitsu Y, Tajiri K, Nakayama Y, Kawai K, Kudo H, Hirano K, Atarashi Y, Yata Y, Yasumura S, Takahara T, Sugiyama T. Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil. World J Hepatol 2010; 2(12): 442-446
- URL: https://www.wjgnet.com/1948-5182/full/v2/i12/442.htm
- DOI: https://dx.doi.org/10.4254/wjh.v2.i12.442